Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company’s bid to get the Supreme ...

The Trump administration urged the US Supreme Court to take up Bayer AG’s appeal targeting thousands of lawsuits blaming its ...

In a brief filed with the Court, U.S. Solicitor General D. John Sauer supported Bayer’s view that federal law blocks ...

The company said the government’s support would be significant and could help limit tens of thousands of lawsuits.

President Donald Trump's administration urged the U.S. Supreme Court on Monday to take up Bayer’s bid to curtail thousands of lawsuits claiming its Roundup weedkiller causes cancer, pushing the ...

The Trump administration has thrown its support behind Bayer as the company urges the U.S. Supreme Court to review thousands of lawsuits alleging its Roundup weedkiller causes cancer. In a filing ...

Asundexian's Phase 3 study results raise hopes for a new class of cardiovascular drugs that has seen clinical setbacks.

The leaders said the company’s collaborative culture keeps patient benefit at the center of decision-making. To learn more about how Bayer’s model is transforming its pipeline, listen to the full ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.

Bayer is deploying GenAI tools at scale while many corporates struggle to find ROI on AI. The difference may lie in a 12-year ...

Bayer’s consensus analyst price target has risen modestly from €28.71 to €29.57, indicating a slight increase in confidence ...

The support of the U.S. Government is an important step and good news for U.S. farmers, who need regulatory clarity. The stakes could not be higher as the misapplication of federal law jeopardizes the ...